Bioactive Food Ingredients in Managing Inflammatory Diseases

Inflammatory and non-communicable diseases (NCDs) have a significant impact on public health as well as socio-economic conditions across the globe. According to the WHO (World Health Organization), NCDs kill a devastating 41 million humans every year. Sufficient nutrition and good health depend on eating a balanced diet. It guards against a variety of chronic NCDs, including cancer, diabetes and heart disease. A balanced diet must include a range of foods. Advances in science, technology, and the interpretation of food chemistry and biological functions by food researchers have led to a shift in consumers' perceptions of food functions, from satisfaction and nutrition to health. Long-term unhealthy diets cause many human chronic diseases, as epidemiological research demonstrates. Many bioactive food components, such as polyphenols, polysaccharides, flavonoids, peptides and saponins, offer multiple health benefits. Research also demonstrates that food plays a significant role in the majority of acute and chronic human diseases. In order to prevent chronic diseases, improve quality of life, and eventually develop new or enhanced healthy meals, it is crucial to have a deeper understanding of the bioaccessibility, safety concerns and underlying health-promoting mechanisms of food-derived bioactive components. Despite tremendous advancements in therapeutics, the cure of dreadful diseases such as cancer, neurodegenerative disease, colitis and rheumatoid arthritis is still a significant challenge. Furthermore, therapeutic repercussions in terms of side effects and the emergence of multi-drug resistance make therapeutics more complicated.

Bioactive Food Ingredients in Managing Inflammatory Diseases illustrates the significance of bioactive food ingredients in tackling inflammation and inflammatory diseases. The potential of food ingredients as anti-oxidative and anti-inflammatory strategies, their mechanistic insight into scavenging free radicals, and their application in managing inflammation and inflammatory diseases. With the focus on challenges and advances in using bioactive food ingredients for enhanced therapeutic efficacy. The text studies the potentiality of bioactive food ingredients in the management of inflammation and inflammatory disease, providing researchers with a valuable single source reference for the very latest in bioactive foods and their use in treating inflammatory diseases. 

Dr. Md. Meraj Ansari is a Research Professor at the Department of Animal Biotechnology, Jeju National University, Jeju City, Republic of Korea. He has completed his Ph.D. in Toxicology from Jamia Hamdard, New Delhi, India, studying the therapeutic effect of natural compounds and the functionality of heavy metals and trace elements in the pathogenesis of rheumatoid arthritis. Subsequently, he had worked as a post-doctoral researcher at the Institute of Nano Science and Technology, Mohali, Punjab, India. He continued his work on nanoformulations of natural compounds and synthetic drugs to block TNF and IL-6 signaling in rheumatoid arthritis and Ulcerative Colitis. Dr Ansari was awarded a Young scientist award in 2019 by Department of Health Research, Ministry of Health and Family welfare, government of India. He had worked as a Young Scientist at the Centre of Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, Punjab, India. His main focus was nanoformulations and drug delivery in cancer therapeutics. His scientific contribution includes more than 24 articles in peer-reviewed international journals and 8 book chapters. He reviewed several research articles for reputed journals, including Environmental toxicology,  Frontiers in pharmacology, Frontiers in nutrition immunology, Frontiers in Oncology, Toxicology mechanism and method, cancer control and many more.

Dr. Nadeem Akhtar, a scientist, is currently making significant strides in the animal health and longevity sector for a leading Canadian company, CBS Bio Platforms Inc. His impressive background demonstrates that he has held a variety of important positions in academia and research throughout his career.

Dr. Akhtar was a Research Associate at the University of Guelph, Canada, where the objective of his work was to improve companion animal's health in order to promote a superior and more health-conscious lifestyle. Prior to assuming this position, he excelled as a postdoctoral researcher at the Department of Chemical Engineering, University of Waterloo, Canada (2019–2021) and the Department of Animal Biosciences, University of Guelph, Canada (2015–2019).

His accomplishments in the National Eligibility Test (NET-2010) and Graduate Aptitude Test (GATE) in Life Sciences (2010) and Biotechnology (2011) further emphasize his academic excellence. He earned his Ph.D. from the esteemed Department of Biotechnology at the Thapar Institute of Engineering and Technology in India.

Dr. Akhtar's scientific contributions are nothing short of remarkable, with over 28 articles published in peer-reviewed international journals as well as 12 book chapters and four edited books. His abilities extend to patent accomplishments, as he has one granted patent to his name. In addition to his research, he has shown his dedication to knowledge advancement by serving as a reviewer for prestigious journals such as RSC Advances, the Journal of Applied Microbiology, Scientific Reports, and Poultry Science.

Dr. Akhtar's career exemplifies dedication and excellence, demonstrating his invaluable contributions to the fields of animal science and biotechnology. His journey continues to motivate and shape the global scientific landscape.